CDTX vs VMC · rev $1.3M vs P/E 35, rev $7.42B
Cidara Therapeutics Inc (CDTX) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
CDTX currently screens at market cap $6.96B. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the CDTX and VMC stock pages for the full models.
Not investment advice.